BRCA1 and BRCA2 in Indian breast cancer patients.
Incidence of breast cancer in Indian women is not as high as in Western countries, nonetheless age-adjusted incidence rates (AAR) have risen from 17.9 to 24.9 per 100,000 from 1965 to 1985. Although these rates are still approximately one quarter to one third of incidence rates in North America and Europe, respectively, due to the large population of women at risk, nearly 80,000 new cases were diagnosed in India in 2000. Although identification of BRCA1 and BRCA2 has greatly increased our understanding of breast cancer genetics in populations of Western European descent, the role of these genes in Indian populations remains unexplored. Analysis of a series of 20 breast cancer patients from North India with either family history of breast and/or ovarian cancer (2 or more affected first degree relatives) or early age of onset (<35 years) led to identification of two novel splice variants (331+1G>T; 4476+2T>C) in BRCA1 (10%). In addition, two BRCA2 missense variants were each identified in more than one patient (two unrelated individuals each) and likely represent population-specific polymorphisms.
Saxena
Sunita
S
Institute of Pathology, Safdarjang Hospital Campus, New Delhi, India. sunita_saxena@yahoo.com
Szabo
Csilla I
CI
Chopin
Sandrine
S
Barjhoux
Laure
L
Sinilnikova
Olga
O
Lenoir
Gilbert
G
Goldgar
David E
DE
Bhatanager
Dinesh
D
D000328:Adult; D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics*; D018567:Breast Neoplasms, Male / Q000235:genetics*; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000737:chemistry / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged; D009154:Mutation
D019313:BRCA1 Protein; D024682:BRCA2 Protein; D004273:DNA, Neoplasm